Posted: Sun., Mar. 13, 2005, 6:00am PT

B'way off; 'Sundays' 784g

Broadway grosses

On Broadway, March always comes in like a lamb, never like a lion. Week 40 (Feb. 28-March 6) was no exception, as 25 shows brought in $12,577,154, down $2,515,508 or 16.67%.

A year ago, the early-March sesh did only marginally better, producing $12.85 million in receipts. Paid attendance then was 200,168 vs. last week's 193,661.

Broadway has certainly seen worse numbers for early March. Two years ago, the musicians' strike KO'd a weekend of performances.

Last week, only two shows increased their receipts. Up $2,759, "700 Sundays" ($783,704) moved into the No. 4 slot on the B.O. chart, ahead of "The Producers" ($710,101), "Hairspray" ($642,146) and the previewing "Spamalot" ($753,039), which saw its gross cut due to benefit tickets.

"The Glass Menagerie" ($311,658), the week's other gainer, did a full eight after the previous session's five previews, its gross up a nifty $52,094. Last-minute replacement Christian Slater went into the show March 4, four days ahead of sked.

Otherwise, freefalls at the box office were more the rule than the exception. Biggest hits were sustained by "Fiddler on the Roof" ($537,847) and "La Cage aux Folles" ($390,029), down $250,780 and $192,273, respectively.

The 19 musicals grossed $10,612,504 for 84.4% of the Broadway total, with attendance of 163,417 at 76.4% of capacity.

The six plays grossed $1,964,650 for 15.6% of the Broadway total, with attendance of 30,244 at 69.9% of capacity.

Average ticket prices were $64.94 for musicals, $64.96 for plays, and $64.94 for all shows.


TALKBACK:

Have an opinion about this article? Be the first to comment




The Middle-East International Film Festival kicks off this fall.


Q What are the top 3 things affecting our industry today?
A. Brian - The interweb, and two other things.more >


Submit this form

VarietyCareers.com

media & entertainment industry jobs online

Featured Jobs

Keywords:
City, State:
© 2008 Reed Business Information, a division of Reed Elsevier Inc. All rights reserved. Use of this website is subject to its Terms & Conditions of Use. View our Privacy Policy.